Elvie develops consumer-focused women’s health products designed to replace outdated medical devices with sleek, home-friendly alternatives. Its product lineup includes the Elvie Trainer app-connected Kegel trainer, the Elvie Pump silent wearable breast pump, and breastfeeding accessories Elvie Catch and Elvie Curve. The company was founded in 2013 by Tania Boler and is headquartered in London. Elvie aims to revolutionise categories such as breast pumps and pelvic-floor health by combining engineering, design, and consumer UX. Financially, Elvie has completed multiple fundraises, bringing total funding to $136 million to date from backers that include BlackRock, Octopus Ventures, and the Business Growth Fund. The most recent capital is intended to enhance women’s well-being and support the company’s product and category expansion. Elvie is a British femtech company that designs consumer health products for women, including the Elvie Pump and app-connected Elvie Trainer. The company has four products on market—Elvie Trainer, Elvie Pump, Elvie Catch and Elvie Curve—and has commercialized two breakthrough, patented and FDA-approved devices. Since launching Elvie Pump in 2018 the business experienced rapid growth, growing 6x in 2019, almost doubling in 2020 and on track to double again in 2021, while launching 10 new markets across Europe and Asia and gaining the No.1 position for Elvie Pump in the US and UK. Elvie plans to expand its product portfolio into other key life stages to become a global platform for women’s health. The Series C proceeds will be used to fund product innovation, geographic expansion and to strengthen operations and infrastructure for the next phase of growth. Elvie is a six-year-old, London-based femtech hardware company known for an app-connected Kegel trainer and a silent wearable breast pump. Its Kegel trainer provides five-minute workouts with real-time biofeedback, while the pump monitors milk volume in real time, tracks pumping history per breast and can be operated remotely. The pump launched in September and had a waitlist of thousands of women. Elvie's long-term plan is to develop products supporting women at every stage of life — prenatal, menopausal and otherwise — and to become a one-stop shop for women's health. Financially, the company has raised nearly $50 million to date and announced a $42 million Series B as its third private financing. The new capital will be used for R&D on upcoming products and to build brand awareness and distribution across the U.S., Canada, Europe and Asia. Launched in 2013, Elvie develops consumer technology focused on women’s health, notably a pelvic floor exercise tracker paired with a mobile app. Its tracker is distributed through major retailers and e-tailers including Amazon, John Lewis, Goop and Violet Grey. The company already operates in 59 countries and generated $1 million in direct sales revenue in 2016. Elvie plans to use new funding to expand into 25 additional countries across the Americas, Europe and Asia-Pacific. It also intends to launch a second device aimed specifically at new mothers before the end of 2017. The business has previously raised seed funding and received government grants to support development and growth.

Total raised

$140M

Funding rounds

4

Latest round

Equity

Latest activity

Apr 2024